Integra LifeSciences Holdings Corporation provided revenue guidance for the fourth quarter and full year 2021. Fourth quarter 2021 revenue is expected to be in a range of $404 million to $406 million, representing an increase of approximately 4% on a reported basis and an increase of approximately 8% on an organic basis compared to the prior year. Revenue is in line with the outlook the Company provided in November and represents a sequential revenue improvement from the third quarter.

The Company expects full-year 2021 reported revenue to be in a range of $1,541 million to $1,543 million, representing an increase of approximately 12% on a reported basis and an increase of approximately 14% on an organic basis.